Life Sciences and Biotech Data to Intelligence Assessment on AWS
Compass UOL · Intelligence & Research
Certification per AWS Marketplace.
Evidence tier Source Confirmed · 4 captures on record
What the publisher says
As described on AWS Marketplace.
Life sciences organizations generate massive volumes of data across clinical trials, research, genomics, and real-world evidence. However, much of this data remains underutilized due to fragmentation across systems, lack of governance, and limited analytics maturity.
Disconnected data environments, inconsistent data quality, and limited access to trusted datasets slow down research timelines, delay decision-making, and increase operational and regulatory risk.
Show the rest of the publisher’s description (31 more lines)
Compass UOL helps life sciences organizations assess and modernize their data landscape on AWS by transforming siloed data into a scalable, governed, and analytics-ready foundation. This assessment evaluates data sources, pipelines, governance models, and analytics capabilities to identify gaps and define a roadmap to move from raw data to actionable intelligence.
Leveraging AWS data and analytics services, including data lakes, governance frameworks, and AI/ML integration points, Compass UOL defines an AWS-native architecture that enables faster insights generation, improved data accessibility, and standardized governance aligned with regulatory requirements.
Customers leave with a clear path to unify their data environment, accelerate analytics initiatives, and enable data-driven decision-making across clinical, research, and operational workflows.
Buyer Problem / Business Trigger
Data silos across clinical, research, and operational systems
Limited ability to generate insights from structured and unstructured datasets
Poor data governance impacting quality, traceability, and compliance
Delays in clinical and research decision-making due to lack of analytics readiness
Delivery Model
Discovery of data landscape and key business priorities
Assessment of data architecture, pipelines, and analytics capabilities
Definition of AWS-native data and intelligence architecture
Roadmap creation for modernization and analytics enablement
Assessment / Engagement Scope
Inventory and evaluation of data sources (clinical trials, RWD, genomics, lab data)
Assessment of data ingestion, storage, and processing pipelines
Review of data governance, quality, lineage, and compliance controls
Evaluation of analytics and reporting capabilities
Identification of opportunities for AI/ML and advanced analytics integration
Design of AWS-native architecture (data lake, analytics, governance layers)
Expected Output / Deliverables
Data maturity and intelligence assessment report
AWS reference architecture for data and analytics in life sciences
Data governance and quality framework
Prioritized use cases for analytics and AI-driven insights
Implementation roadmap for data modernization
Customer Decision Questions
This offer helps the customer answer:
How do we unify clinical and research data into a single, trusted environment?
Which AWS architecture enables scalable and compliant data analytics?
Where can we accelerate insights generation to improve decision-making?
Highlights
Highlighted by the publisher on AWS Marketplace.
Enables real time querying across clinical and research datasets, Reduces time to insight for trials and research, Supports compliant access to regulated data, Defines AWS native architecture for regulated environments
Agent build and provenance
See the full provenance
The layer-by-layer build, the evidence behind each claim, the risk basis and the cross-marketplace links are open to any account. Some rows are disclosed, some the source leaves Unknown; a free account shows you which.
Sources
Linked repositories
Unknown means this listing does not publish a repository. It is not a statement that the code is closed, and a linked repository is not a claim that the publisher wrote it: the registry computes that relationship privately and does not publish it.
Evidence risk is the share of the build you cannot see before you deploy, not a security rating. Sign in to see the layer-by-layer basis for this band.